<DOC>
	<DOCNO>NCT02646982</DOCNO>
	<brief_summary>This study intend investigate effect candesartan , blood pressure medication , cognitive function think skill early mild memory difficulty , also call mild cognitive impairment MCI .</brief_summary>
	<brief_title>Candesartan 's Effects Alzheimer 's Disease And Related Biomarkers</brief_title>
	<detailed_description>This double-blind placebo-control randomize clinical trial compare candesartan placebo individual mild cognitive impairment ( MCI ) also positive Alzheimer 's Disease ( AD ) biomarkers . The investigator ass block effect Ang II , crucial mediator neuro-vascular injury , use angiotensin receptor blocker ( ARBs ) address shortcoming current treatment regimen . They also assess safety dose-response target engagement treatment escalate dos candesartan study .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<criteria>Mild Cognitive Impairment Evidence Alzheimer 's Disease Intolerance ARBs Current use ARBs , ACEI antihypertensive medication use specifically hypertensive therapy SBP le 110 great 140 mm Hg/ DBP le 50 mm Hg great 100 mm Hg ; Renal disease ( Creatinine &gt; 2.0 mg/dl ) , hyperkalemia ( K &gt; 5.5 meq/dl ) , platelets &lt; 50,000/Î¼l , INR &gt; 1.5 . Active medical psychiatric disease judgment investigator would affect safety subject scientific integrity study ; Uncontrolled congestive heart failure reflect poor exercise tolerance shortness breath ; Diabetes mellitus ; History stroke past 3 year ; Inability perform study procedure include LP , MRI ( eg metal implant cardiac pacemaker ) , cognitive assessment ; History increase intracranial pressure ( ICP ) bleed diathesis ( disease state use anticoagulant warfarin , heparin related product , rivaroxaban Xarelto , apixaban Eliquis , edoxaban Savaysa , dabigatran Pradaxa ) ; Women childbearing potential ( nonmenopausal ) ; In unable demonstrate understood detail study ( ie lack decisionalcapacity consent ) , study partner/surrogate sign behalf require , otherwise exclude ; Current use Lithium , candesartan may increase lithium concentration toxic level .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>Vascular function</keyword>
	<keyword>Neuroinflammation</keyword>
</DOC>